- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
18 result(s) found for: Bayesian Analysis.
Displaying page 1 of 1.
EudraCT Number: 2010-024026-38 | Sponsor Protocol Number: mex201011 | Start Date*: 2012-01-10 |
Sponsor Name:Radboud University Nijmegen Medical Center | ||
Full Title: Combining N-of-1 trials to estimate population clinical effectiveness of drugs using Bayesian hierarchical modeling. The case of Mexilitin for patients with Non-Dystrophic Myotonia. | ||
Medical condition: Patients with non-dystrophic myotonic syndromes (NDMs). NDMs are caused by mutations in the gene encoding for the skeletal muscle sodium (SCN4A) or chloride (CLCN1) channel. In this study patient... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-005169-39 | Sponsor Protocol Number: D9914C00002 | Start Date*: 2005-08-11 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A single-blind single arm study to validate the Reflux Disease Questionnaire (RDQ) for the diagnosis of reflux disease in primary care in patients treated with esomeprazole 40 mg o.d. | ||
Medical condition: Symptoms from the upper gastrointestinal tract | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) GB (Completed) DE (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001857-14 | Sponsor Protocol Number: UC-0101/1709 | Start Date*: 2018-04-18 |
Sponsor Name:UNICANCER | ||
Full Title: A phase I/II basket trial evaluating a combination of Metronomic Oral Vinorelbine plus anti-PD-L1/anti-CTLA4 ImmunothErapy in patients with advanced solid tumours. | ||
Medical condition: Patients with Histologically confirmed locally advanced or metastatic solid tumours, resistant to conventional therapies, and candidate to experimental therapy by local clinical board, from the fol... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002795-13 | Sponsor Protocol Number: TACRO-Omics | Start Date*: 2020-04-23 |
Sponsor Name:Fundación de Investigación Hospital Universitario La Paz | ||
Full Title: Identification of "omic" biomarkers and their inter and intra-individual variability that allow improvement in the individualization of tacrolimus: uncontrolled clinical trial in pediatric patients... | ||
Medical condition: Pediatric patients with renal transplantation (under stable treatment with tacrolimus as immunosuppressant) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001402-38 | Sponsor Protocol Number: CTU/2020/352 | Start Date*: 2020-10-20 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: An international, Bayesian platform adaptive, randomized, placebo-controlled trial assessing the effectiveness of candidate interventions in preventing COVID-19 disease in healthcare workers. | |||||||||||||
Medical condition: Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000340-34 | Sponsor Protocol Number: OPTIMUS | Start Date*: 2016-06-22 | |||||||||||
Sponsor Name:HOSPITAL UNIVERSITARI DE BELLVITGE | |||||||||||||
Full Title: Dose optimization of tacrolimus using Bayesian prediction including pharmacogenetic variables in renal transplant patients. | |||||||||||||
Medical condition: PROPHYLAXIS OF ALLOGRAFT REJECTION AFTER RENAL TRASPLANT. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000625-37 | Sponsor Protocol Number: BED-004 | Start Date*: 2015-08-28 | |||||||||||
Sponsor Name:Blue Earth Diagnostics Limited | |||||||||||||
Full Title: A phase 3, open-label study to assess the clinical utility of fluciclovine (18F) PET/CT in patients with prostate cancer with biochemical recurrence after radical treatment | |||||||||||||
Medical condition: Prostate cancer with biochemical recurrence after radical treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002814-29 | Sponsor Protocol Number: CETB115E2403 | Start Date*: 2017-03-21 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A | |||||||||||||
Full Title: SOAR Trial, A two-part study: Interventional phase II single-arm trial to assess efficacy and safety of Eltrombopag combined with cyclosporine as first line therapy in patients with severe acquired... | |||||||||||||
Medical condition: First-line severe aplastic anaemia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Restarted) NL (Completed) HU (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001063-43 | Sponsor Protocol Number: 11/0078 | Start Date*: 2011-09-09 | |||||||||||
Sponsor Name:University College London (UCL) | |||||||||||||
Full Title: A Phase III single-blind, randomised, placebo controlled trial of long term therapy in patients with stable COPD using Moxifloxacin, Azithromycin, and Doxycycline: a Bayesian decision analysis, inc... | |||||||||||||
Medical condition: COPD- Chronic Obstructive Pulmonary Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002592-34 | Sponsor Protocol Number: RID-TB:Dx | Start Date*: 2020-08-28 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: Research to Improve the Detection and Treatment of Latent Tuberculosis Infection: Diagnostics (RID-TB:Dx) A randomised controlled trial to evaluate the effectiveness of using the RD-1 based C Tb s... | |||||||||||||
Medical condition: Latent Tuberculosis infection (LTBI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002448-42 | Sponsor Protocol Number: GMI-1271-201 | Start Date*: 2015-03-12 | |||||||||||
Sponsor Name:GlycoMimetics, Inc. | |||||||||||||
Full Title: A Phase I/II, open-label multicenter study to determine safety, pharmacokinetics and efficacy of GMI-1271 in combination with chemotherapy in patients with acute myeloid leukemia | |||||||||||||
Medical condition: Acute myeloid leukemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000814-73 | Sponsor Protocol Number: RG_14-072 | Start Date*: 2016-07-15 | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: National Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer | |||||||||||||
Medical condition: Metastatic or locally advanced non-small cell lung cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003117-41 | Sponsor Protocol Number: CAIN457D2204 | Start Date*: 2012-02-03 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, double-blind, placebo controlled, multiple dose study to evaluate the safety, tolerability, and efficacy of intravenous administration of secukinumab (AIN457) in patients with asthma ... | |||||||||||||
Medical condition: Asthma not adequately controlled with inhaled corticosteroids and long acting beta-agonists | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000261-36 | Sponsor Protocol Number: FGTW-1004 | Start Date*: 2013-11-29 | ||||||||||||||||
Sponsor Name:LFB Biotechnologies | ||||||||||||||||||
Full Title: Clinical pharmacology, efficacy and safety study of FGTW in paediatric patients with severe congenital fibrinogen deficiency | ||||||||||||||||||
Medical condition: Afibrinogenaemia or severe hypofibrinogenaemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022504-42 | Sponsor Protocol Number: I4V-MC-JADA | Start Date*: 2011-06-07 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2b Study of LY3009104 in Patients with Active Rheumatoid Arthritis on background Methotrexate Therapy | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-008359-40 | Sponsor Protocol Number: CAIN457A2202 | Start Date*: 2009-05-07 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter, randomised, double-blind, placebo-controlled, parallel-group proof- of-concept study to assess the efficacy, safety and tolerability of two single i.v. infusions of AIN457 10 mg/kg (... | |||||||||||||
Medical condition: Moderate to severe Crohn's disease (CDAI = 220 and =450) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) PL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003733-38 | Sponsor Protocol Number: ORP-TMZ-I-b | Start Date*: 2021-11-27 | |||||||||||||||||||||||||||||||
Sponsor Name:ORPHELIA Pharma | |||||||||||||||||||||||||||||||||
Full Title: TEMOkids study (ORP-TMZ-I- b): A Population pharmacokinetic, acceptability and safety study for KIMOZO, a paediatric oral suspension of temozolomide | |||||||||||||||||||||||||||||||||
Medical condition: Different pediatric cancers such as malignant glioma and also relapsed or refractory neuroblastoma, rhabdomyosarcoma, medulloblastoma, and Ewing sarcoma, for which treatment with the cytotoxic tem... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) GB (GB - no longer in EU/EEA) DE (Completed) ES (Ongoing) NL (Completed) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001489-17 | Sponsor Protocol Number: SIOPENRNET003 | Start Date*: 2006-11-17 |
Sponsor Name:St. Anna Kinderkrebsforschung e.V. | ||
Full Title: High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) | ||
Medical condition: High Risk Neuroblastoma | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) ES (Restarted) GB (GB - no longer in EU/EEA) BE (Ongoing) DK (Restarted) IE (Ongoing) HU (Ongoing) FI (Ongoing) SI (Completed) PL (Ongoing) GR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.